Browse all episodes of our podcast, The Life Science Rundown.

Subscribe to The Life Science Rundown.

Submit your work email below and get each new episode delivered directly to your inbox.

EPISODE #001 A Look at FDA's Pandemic Inspections Q&A Guidance



The FDA Group’s CEO, Nick Capman, breaks down the FDA’s Q&A guidance on drug and biologic inspections during the pandemic, pointing out the important takeaways manufacturers should consider and prepare for. Read our blog post for a written breakdown of the key takeaways. We've also written on FDA's more recent guidance outlining its expectations for resuming normal manufacturing operations during the pandemic. Read that post here. Need expert quality system remediation assistance? Learn more and get in touch.


Have a topic you'd like us to cover? Submit a topic request and we'll consider it for future episodes.